Evolva Holding SA

Swiss Stock Exchange EVE.SW

Evolva Holding SA Net Cash Used For Investing Activities for the year ending December 31, 2023: USD 18.94 M

Evolva Holding SA Net Cash Used For Investing Activities is USD 18.94 M for the year ending December 31, 2023, a 1,093.35% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Evolva Holding SA Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -1.91 M, a 62.50% change year over year.
  • Evolva Holding SA Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -5.09 M, a 19.59% change year over year.
  • Evolva Holding SA Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -6.32 M, a -14.89% change year over year.
  • Evolva Holding SA Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -5.51 M, a 55.42% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
Loading...
SV Wall Street
Swiss Stock Exchange: EVE.SW

Evolva Holding SA

CEO Mr. Gerhard Lobmaier
IPO Date May 3, 2005
Location Switzerland
Headquarters Duggingerstrasse 23
Employees 49
Sector Consumer Discretionary
Industries
Description

Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.

Similar companies

BSLN.SW

Basilea Pharmaceutica AG

USD 43.76

-1.99%

SANN.SW

Santhera Pharmaceuticals Holding AG

USD 17.87

-4.83%

MBTN.SW

Meyer Burger Technology AG

USD 1.80

-8.93%

StockViz Staff

February 6, 2025

Any question? Send us an email